Site-002 — Dakota Dunes, South Dakota

Site-002 is a clinical research site located in Dakota Dunes, South Dakota, United States 57049.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site-002 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: IgA Nephropathy.

Sponsors: Biohaven Therapeutics Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dakota Dunes

Browse all research sites in South Dakota · View every site in Dakota Dunes

• Meridian Clinical Research
• Dunes Clinical Research
• Research Site
• Meridian Clinical Research - Dakota Dunes
• Dunes Eye Consultants
• Novo Nordisk Investigational Site
• GSK Investigational Site
• Clinical Research Site 374
• Meridian Research
• Meridian Clincial Research
• Ironwood Investigational Site
• Investigator Site - Dakota Dunes

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site-002?

Site-002 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site-002 conducted?

Site-002 has 1 clinical trials on record, with 1 currently active. Their work covers IgA Nephropathy.

Is Site-002 accredited by Crixeo Clinical Trials?

Site-002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site-002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.